Cas:104774-87-0 Cinacalcet metabolite M4 manufacturer & supplier

Chemical Name:Cinacalcet metabolite M4

CAS.NO:104774-87-0

Synonyms:3-[3-(Trifluoromethyl)phenyl]-1-propanamine;Benzenepropanamine, 3-(trifluoromethyl)-

Molecular Formula:C₁₀H₁₂F₃N

Molecular Weight:203.204

HS Code:2921499090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:222.2±40.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.468

PSA:26.02000

Exact Mass:203.092178

LogP:2.40

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-[3-(Trifluoromethyl)phenyl]-1-propanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenepropanamine, 3-(trifluoromethyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenepropanamine, 3-(trifluoromethyl)- Use and application,3-[3-(Trifluoromethyl)phenyl]-1-propanamine technical grade,usp/ep/jp grade.

Related News: It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. Cinacalcet metabolite M4 manufacturer The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. Cinacalcet metabolite M4 supplier It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. Cinacalcet metabolite M4 vendor It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance. Cinacalcet metabolite M4 factory The technology supports breakthroughs in medical research and is widely used by major global pharmaceutical companies to advance drug discovery & development and provide data to support regulatory submissions.